Literature DB >> 34782742

A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.

David Dilworth1,2, Ronan P Hanley3,4, Renato Ferreira de Freitas5,6, Abdellah Allali-Hassani5,7, Mengqi Zhou5,8, Naimee Mehta3,9, Matthew R Marunde10, Suzanne Ackloo5, Raquel Arminda Carvalho Machado5, Aliakbar Khalili Yazdi5, Dominic D G Owens5, Victoria Vu5, David Y Nie5,11, Mona Alqazzaz5, Edyta Marcon12, Fengling Li5, Irene Chau5, Albina Bolotokova5, Su Qin5,13, Ming Lei5,8, Yanli Liu5,14, Magdalena M Szewczyk5, Aiping Dong5, Sina Kazemzadeh3, Tigran Abramyan3,15, Irina K Popova10, Nathan W Hall10, Matthew J Meiners10, Marcus A Cheek10, Elisa Gibson5, Dmitri Kireev3, Jack F Greenblatt12, Michael-C Keogh10, Jinrong Min5,8, Peter J Brown5, Masoud Vedadi5,16, Cheryl H Arrowsmith5,17, Dalia Barsyte-Lovejoy18,19, Lindsey I James20, Matthieu Schapira21,22.   

Abstract

Nuclear receptor-binding SET domain-containing 2 (NSD2) is the primary enzyme responsible for the dimethylation of lysine 36 of histone 3 (H3K36), a mark associated with active gene transcription and intergenic DNA methylation. In addition to a methyltransferase domain, NSD2 harbors two proline-tryptophan-tryptophan-proline (PWWP) domains and five plant homeodomains (PHDs) believed to serve as chromatin reading modules. Here, we report a chemical probe targeting the N-terminal PWWP (PWWP1) domain of NSD2. UNC6934 occupies the canonical H3K36me2-binding pocket of PWWP1, antagonizes PWWP1 interaction with nucleosomal H3K36me2 and selectively engages endogenous NSD2 in cells. UNC6934 induces accumulation of endogenous NSD2 in the nucleolus, phenocopying the localization defects of NSD2 protein isoforms lacking PWWP1 that result from translocations prevalent in multiple myeloma (MM). Mutations of other NSD2 chromatin reader domains also increase NSD2 nucleolar localization and enhance the effect of UNC6934. This chemical probe and the accompanying negative control UNC7145 will be useful tools in defining NSD2 biology.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34782742      PMCID: PMC9189931          DOI: 10.1038/s41589-021-00898-0

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  55 in total

Review 1.  The nucleolus.

Authors:  P J Shaw; E G Jordan
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

2.  Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.

Authors:  Michiel Vermeulen; H Christian Eberl; Filomena Matarese; Hendrik Marks; Sergei Denissov; Falk Butter; Kenneth K Lee; Jesper V Olsen; Anthony A Hyman; Henk G Stunnenberg; Matthias Mann
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

3.  PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage.

Authors:  Jinfang Zhang; Yu-Ru Lee; Fabin Dang; Wenjian Gan; Archita Venugopal Menon; Jesse M Katon; Chih-Hung Hsu; John M Asara; Priyanka Tibarewal; Nicholas R Leslie; Yang Shi; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cancer Discov       Date:  2019-06-19       Impact factor: 39.397

Review 4.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

5.  Regulation of SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient availability.

Authors:  Leixiang Yang; Tanjing Song; Lihong Chen; Neha Kabra; Hong Zheng; John Koomen; Edward Seto; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

6.  The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.

Authors:  Josh Lauring; Abde M Abukhdeir; Hiroyuki Konishi; Joseph P Garay; John P Gustin; Qiuju Wang; Robert J Arceci; William Matsui; Ben Ho Park
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

7.  In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

Authors:  Jonathan J Keats; Tony Reiman; Christopher A Maxwell; Brian J Taylor; Loree M Larratt; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

8.  MMSET is the key molecular target in t(4;14) myeloma.

Authors:  F Mirabella; P Wu; C P Wardell; M F Kaiser; B A Walker; D C Johnson; G J Morgan
Journal:  Blood Cancer J       Date:  2013-05-03       Impact factor: 11.037

9.  CellProfiler 3.0: Next-generation image processing for biology.

Authors:  Claire McQuin; Allen Goodman; Vasiliy Chernyshev; Lee Kamentsky; Beth A Cimini; Kyle W Karhohs; Minh Doan; Liya Ding; Susanne M Rafelski; Derek Thirstrup; Winfried Wiegraebe; Shantanu Singh; Tim Becker; Juan C Caicedo; Anne E Carpenter
Journal:  PLoS Biol       Date:  2018-07-03       Impact factor: 8.029

10.  Covalent inhibition of NSD1 histone methyltransferase.

Authors:  Huang Huang; Christina A Howard; Sergei Zari; Hyo Je Cho; Shirish Shukla; Hao Li; Juliano Ndoj; Paula González-Alonso; Caroline Nikolaidis; Joshua Abbott; David S Rogawski; Mykhaylo A Potopnyk; Katarzyna Kempinska; Hongzhi Miao; Trupta Purohit; Andrew Henderson; Anna Mapp; Maria Luisa Sulis; Adolfo Ferrando; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2020-08-31       Impact factor: 15.040

View more
  6 in total

Review 1.  Lysine methyltransferase inhibitors: where we are now.

Authors:  Alessandra Feoli; Monica Viviano; Alessandra Cipriano; Ciro Milite; Sabrina Castellano; Gianluca Sbardella
Journal:  RSC Chem Biol       Date:  2021-12-13

2.  Discovery of a First-in-Class Degrader for Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and Ikaros/Aiolos.

Authors:  Fanye Meng; Chenxi Xu; Kwang-Su Park; H Ümit Kaniskan; Gang Greg Wang; Jian Jin
Journal:  J Med Chem       Date:  2022-07-27       Impact factor: 8.039

Review 3.  The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.

Authors:  Iuliia Topchu; Rajendra P Pangeni; Igor Bychkov; Sven A Miller; Evgeny Izumchenko; Jindan Yu; Erica Golemis; John Karanicolas; Yanis Boumber
Journal:  Cell Mol Life Sci       Date:  2022-05-09       Impact factor: 9.207

4.  Covalent labeling of a chromatin reader domain using proximity-reactive cyclic peptides.

Authors:  Meng Yao Zhang; Hyunjun Yang; Gloria Ortiz; Michael J Trnka; Nektaria Petronikolou; Alma L Burlingame; William F DeGrado; Danica Galonić Fujimori
Journal:  Chem Sci       Date:  2022-05-12       Impact factor: 9.969

5.  A trivalent nucleosome interaction by PHIP/BRWD2 is disrupted in neurodevelopmental disorders and cancer.

Authors:  Marc A J Morgan; Irina K Popova; Anup Vaidya; Jonathan M Burg; Matthew R Marunde; Emily J Rendleman; Zachary J Dumar; Rachel Watson; Matthew J Meiners; Sarah A Howard; Natalia Khalatyan; Robert M Vaughan; Scott B Rothbart; Michael-C Keogh; Ali Shilatifard
Journal:  Genes Dev       Date:  2021-11-24       Impact factor: 12.890

6.  A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II.

Authors:  Yanli Liu; Aman Iqbal; Weiguo Li; Zuyao Ni; Yalong Wang; Jurupula Ramprasad; Karan Joshua Abraham; Mengmeng Zhang; Dorothy Yanling Zhao; Su Qin; Peter Loppnau; Honglv Jiang; Xinghua Guo; Peter J Brown; Xuechu Zhen; Guoqiang Xu; Karim Mekhail; Xingyue Ji; Mark T Bedford; Jack F Greenblatt; Jinrong Min
Journal:  Nat Commun       Date:  2022-09-16       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.